China’s healthcare regulator has pledged to investigate the quality of drugs under a new list covered by national insurance, after policy advisers in Shanghai warned that they might be substandard.

Medicare plans have a list of medications, both brand-name and generic, they cover. This list is called a formulary. You can use it when comparing plans. Share on Pinterest alvarez/Getty Images ...

The National Institute for Occupational Safety and Health (NIOSH) has published the 2024 update to its List of Hazardous Drugs in Healthcare Settings, marking the first revision since 2016.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of federal price negotiations, which are scheduled to begin this year ...

Ozempic, Rybelsus and Wegovy top the list of the newest drugs selected for Medicare Part D price negotiation, part of the Inflation Reduction Act. CMS this morning announced the selection of 15 ...

Proposed changes to this list are open for consultation. Learn about the consultation and how to provide your feedback. The consultation closes on March 8, 2025. Drugs included on the list for ...

Blockbuster diabetes drug Ozempic is on the list. That means the federal government and the pharmaceuticals industry are about to go head-to-head once again. The Centers for Medicare and Medicaid ...

And how much does it really cost to bring a drug to market? Increasingly, though, these debates are happening when everyone knows that the list price is not the ‘real’ price to be paid ...

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze.

Government researchers predict that the use of diabetes drug Ozempic and Wegovy for weight loss would raise the U.S. deficit over the next 10 years at its current price. Ozempic has a list price ...